Drugmaker Petitions FDA to Revoke Sublocade Orphan Designation

Drugmaker Petitions FDA to Revoke Sublocade Orphan Designation

Source: 
RAPS.org
snippet: 

A citizen petition filed last week by law firm Goodwin Procter on behalf of Pennsylvania-based drugmaker Braeburn calls on the US Food and Drug Administration (FDA) to revoke the orphan designation granted to Indivior’s opioid use disorder treatment Sublocade (buprenorphine extended-release injection).